Literature DB >> 8097494

Specificity of S fimbriae on recombinant Escherichia coli: preferential binding to gangliosides expressing NeuGc alpha (2-3)Gal and NeuAc alpha (2-8)NeuAc.

F G Hanisch1, J Hacker, H Schroten.   

Abstract

The adhesins of Escherichia coli strains HB101(pANN801-13) and HB101(pAZZ50), which express S fimbriae encoded by a recombinant plasmid containing the sfaI and sfaII gene clusters, respectively, were characterized with regard to the detailed structural requirements of their binding to sialyloligosaccharides on (neo)glycoproteins and (neo)glycolipids. From binding and binding inhibition studies in solid-phase enzyme immunoassays with isolated S fimbriae, several major conclusions can be drawn. S fimbriae bind specifically to sialic acid on gangliosides. The most active structural variant of sialic acid on GM3 ganglioside is N-glycolylneuraminic acid (NeuGc). In contrast to previous reports, high binding activities were measured also for b-series gangliosides expressing NeuAc alpha (2-8)NeuAc. In agreement with earlier studies, the site of sialic acid substitution to subterminal sugars strongly influences the binding to sialyloligosaccharides, i.e., alpha-6-linked sialic acid is only poorly recognized by the adhesin compared with alpha-3-linked sialic acid. C-8 and C-9 hydroxyl groups form essential structural elements of sialic acid in the binding event.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097494      PMCID: PMC280810          DOI: 10.1128/iai.61.5.2108-2115.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  [ON THE PRESENCE OF N-GLYCOLYLNEURAMINIC ACID IN APES].

Authors:  G UHLENBRUCK; J SCHMITT
Journal:  Naturwissenschaften       Date:  1965-04

2.  Occurrence of unique polysialosyl carbohydrate units in glycoproteins of developing brain.

Authors:  J Finne
Journal:  J Biol Chem       Date:  1982-10-25       Impact factor: 5.157

3.  Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis.

Authors:  T K Korhonen; M V Valtonen; J Parkkinen; V Väisänen-Rhen; J Finne; F Orskov; I Orskov; S B Svenson; P H Mäkelä
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

4.  Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers.

Authors:  Y Hirabayashi; H Kasakura; M Matsumoto; H Higashi; S Kato; N Kasai; M Naiki
Journal:  Jpn J Cancer Res       Date:  1987-03

5.  Characterization of pili associated with Escherichia coli O18ac.

Authors:  P Wevers; R Picken; G Schmidt; B Jann; K Jann; J R Golecki; M Kist
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

6.  Carbohydrate structures of hen ovomucoid. A mass spectrometric analysis.

Authors:  H Egge; J Peter-Katalinić; J Paz-Parente; G Strecker; J Montreuil; B Fournet
Journal:  FEBS Lett       Date:  1983-06-13       Impact factor: 4.124

7.  Escherichia coli fimbriae recognizing sialyl galactosides.

Authors:  T K Korhonen; V Väisänen-Rhen; M Rhen; A Pere; J Parkkinen; J Finne
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.490

8.  Cloning and characterization of genes involved in production of mannose-resistant, neuraminidase-susceptible (X) fimbriae from a uropathogenic O6:K15:H31 Escherichia coli strain.

Authors:  J Hacker; G Schmidt; C Hughes; S Knapp; M Marget; W Goebel
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

9.  Escherichia coli strains binding neuraminyl alpha 2-3 galactosides.

Authors:  J Parkkinen; J Finne; M Achtman; V Väisänen; T K Korhonen
Journal:  Biochem Biophys Res Commun       Date:  1983-03-16       Impact factor: 3.575

10.  Identification of the O-linked sialyloligosaccharides of glycophorin A as the erythrocyte receptors for S-fimbriated Escherichia coli.

Authors:  J Parkkinen; G N Rogers; T Korhonen; W Dahr; J Finne
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

View more
  8 in total

1.  Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

Authors:  Robert M Anthony; Falk Nimmerjahn; David J Ashline; Vernon N Reinhold; James C Paulson; Jeffrey V Ravetch
Journal:  Science       Date:  2008-04-18       Impact factor: 47.728

2.  Prevalence of pathogenicity island IICFT073 genes among extraintestinal clinical isolates of Escherichia coli.

Authors:  Nick J Parham; Samantha J Pollard; Roy R Chaudhuri; Scott A Beatson; Mickaël Desvaux; Michael A Russell; Joaquim Ruiz; Amanda Fivian; Jordi Vila; Ian R Henderson
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

3.  Fab-independent antiadhesion effects of secretory immunoglobulin A on S-fimbriated Escherichia coli are mediated by sialyloligosaccharides.

Authors:  H Schroten; C Stapper; R Plogmann; H Köhler; J Hacker; F G Hanisch
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

4.  Blockade of invariant TCR-CD1d interaction specifically inhibits antibody production against blood group A carbohydrates.

Authors:  Hirofumi Tazawa; Toshimitsu Irei; Yuka Tanaka; Yuka Igarashi; Hirotaka Tashiro; Hideki Ohdan
Journal:  Blood       Date:  2013-08-13       Impact factor: 22.113

5.  S fimbriae of uropathogenic Escherichia coli bind to primary human renal proximal tubular epithelial cells but do not induce expression of intercellular adhesion molecule 1.

Authors:  B Kreft; M Placzek; C Doehn; J Hacker; G Schmidt; G Wasenauer; M R Daha; F J van der Woude; K Sack
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

Review 6.  Sialic acids in molecular and cellular interactions.

Authors:  S Kelm; R Schauer
Journal:  Int Rev Cytol       Date:  1997

Review 7.  Immunoglobulin Glycosylation - An Unexploited Potential for Immunomodulatory Strategies in Farm Animals.

Authors:  Kristina Zlatina; Sebastian P Galuska
Journal:  Front Immunol       Date:  2021-10-18       Impact factor: 7.561

Review 8.  Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces.

Authors:  Jiri Mestecky; Michael W Russell
Journal:  Immunol Lett       Date:  2009-04-05       Impact factor: 3.685

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.